Cargando…

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy

In 1975 Matas and co-workers were the first in the world literature to show an increased risk of malignant tumor occurrence in the group of hemodialyzed patients and kidney transplant recipients. The report is an analysis of world literature from the last 35 years in reference to epidemiology as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kade, Grzegorz, Lubas, Arkadiusz, Bodnar, Lubomir, Szczylik, Cezary, Wańkowicz, Zofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687441/
https://www.ncbi.nlm.nih.gov/pubmed/23788914
http://dx.doi.org/10.5114/wo.2012.31765
_version_ 1782273928461287424
author Kade, Grzegorz
Lubas, Arkadiusz
Bodnar, Lubomir
Szczylik, Cezary
Wańkowicz, Zofia
author_facet Kade, Grzegorz
Lubas, Arkadiusz
Bodnar, Lubomir
Szczylik, Cezary
Wańkowicz, Zofia
author_sort Kade, Grzegorz
collection PubMed
description In 1975 Matas and co-workers were the first in the world literature to show an increased risk of malignant tumor occurrence in the group of hemodialyzed patients and kidney transplant recipients. The report is an analysis of world literature from the last 35 years in reference to epidemiology as well as the profile of screening tests and diagnostic methods related to malignant tumors in the population with end stage renal disease, especially hemodialyzed patients.
format Online
Article
Text
id pubmed-3687441
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-36874412013-06-20 Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy Kade, Grzegorz Lubas, Arkadiusz Bodnar, Lubomir Szczylik, Cezary Wańkowicz, Zofia Contemp Oncol (Pozn) Review In 1975 Matas and co-workers were the first in the world literature to show an increased risk of malignant tumor occurrence in the group of hemodialyzed patients and kidney transplant recipients. The report is an analysis of world literature from the last 35 years in reference to epidemiology as well as the profile of screening tests and diagnostic methods related to malignant tumors in the population with end stage renal disease, especially hemodialyzed patients. Termedia Publishing House 2012-11-20 2012 /pmc/articles/PMC3687441/ /pubmed/23788914 http://dx.doi.org/10.5114/wo.2012.31765 Text en Copyright © 2012 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kade, Grzegorz
Lubas, Arkadiusz
Bodnar, Lubomir
Szczylik, Cezary
Wańkowicz, Zofia
Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title_full Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title_fullStr Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title_full_unstemmed Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title_short Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
title_sort malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687441/
https://www.ncbi.nlm.nih.gov/pubmed/23788914
http://dx.doi.org/10.5114/wo.2012.31765
work_keys_str_mv AT kadegrzegorz malignanttumorsinpatientswithendstagerenalfailureundergoingrenalreplacementtherapy
AT lubasarkadiusz malignanttumorsinpatientswithendstagerenalfailureundergoingrenalreplacementtherapy
AT bodnarlubomir malignanttumorsinpatientswithendstagerenalfailureundergoingrenalreplacementtherapy
AT szczylikcezary malignanttumorsinpatientswithendstagerenalfailureundergoingrenalreplacementtherapy
AT wankowiczzofia malignanttumorsinpatientswithendstagerenalfailureundergoingrenalreplacementtherapy